During the past decade, Kyung Hee University Hospital at Gangdong conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 12 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 9 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyung Hee University Hospital at Gangdong" #1 sponsor was "Kyung Hee University Hospital at Gangdong" with 15 trials, followed by "Kyunghee University Medical Center" with 15 trials sponsored, "Pfizer" with 9 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored and "Jaseng Medical Foundation" with 7 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyung Hee University Hospital at Gangdong" #1 collaborator was "Kyung Hee University Hospital at Gangdong" with 13 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 3 trials as a collaborator, "DongGuk University" with 3 trials as a collaborator, "Korea Institute of Oriental Medicine" with 3 trials as a collaborator and "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Kyung Hee University Hospital at Gangdong" are "Hemophilia A" (8 trials), "Rheumatoid Arthritis" (6 trials), "Knee Osteoarthritis" (5 trials), "Chronic Neck Pain" (4 trials) and "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "Kyung Hee University Hospital at Gangdong" in a lesser frequency.

Most popular intervention types in "Kyung Hee University Hospital at Gangdong" are "Drug" (66 trials), "Procedure" (21 trials), "Biological" (16 trials), "Device" (15 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Acupuncture" (4 trials), "Baricitinib" (3 trials), "JOINTSTEM" (3 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kyung Hee University Hospital at Gangdong" are 107 trials for "All" genders, 12 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Kyung Hee University Hospital at Gangdong". 1 are not yet recruiting, 21 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Kyung Hee University Hospital at Gangdong, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kyung Hee University Hospital at Gangdong, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 34 trials that are defined as “Not Applicable".